Synergistic Anastomosis System with AI, IoT, and Blockchain Integration
Legal Citation
Summary of the Inventive Concept
A novel anastomosis system that combines eversion mechanism with AI, IoT, blockchain, and nanomaterial technologies to enhance surgical outcomes, improve data security, and enable real-time monitoring and feedback.
Background and Problem Solved
The original patent addresses the need for efficient and secure anastomosis procedures. However, it lacks the integration of advanced technologies to further improve the process. The new inventive concept solves this problem by incorporating AI, IoT, blockchain, and nanomaterials to create a more powerful and efficient system.
Detailed Description of the Inventive Concept
The system comprises an eversion mechanism, an AI module, an IoT-enabled sensor, and a blockchain-based secure data storage system. The eversion mechanism inverts a distal portion of an opening of a receiving passage, while the AI module analyzes data from the sensor to provide real-time feedback and optimize the eversion process. The IoT-enabled sensor monitors the eversion process and transmits data to a remote monitoring station. The blockchain-based system records and verifies the surgical procedure, ensuring data integrity and security. The nanomaterial-coated eversion mechanism enhances biocompatibility and reduces tissue damage. The system can also be integrated with AI-assisted image analysis and virtual reality visualization for personalized surgical guidance and optimal eversion parameters.
Novelty and Inventive Step
The new claims introduce the synergistic integration of AI, IoT, blockchain, and nanomaterial technologies with the eversion mechanism, providing a novel and non-obvious solution that significantly improves the anastomosis procedure. The inventive step lies in the combination of these distinct technologies to create a more powerful and efficient system.
Alternative Embodiments and Variations
Alternative embodiments may include using different AI algorithms, varying the type of IoT-enabled sensors, or incorporating other advanced materials. The system could also be adapted for use in different surgical procedures or integrated with other medical devices.
Potential Commercial Applications and Market
The synergistic anastomosis system has significant commercial potential in the medical device industry, particularly in the fields of cardiovascular and gastrointestinal surgery. The system's ability to improve surgical outcomes, reduce complications, and enhance data security makes it an attractive solution for hospitals and medical centers.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61B17/1152 |
| A | A61 | A61B17/0469 |
| A | A61 | A61B17/11 |
| A | A61 | A61B90/361 |
| A | A61 | A61B90/37 |
| A | A61 | A61B2017/00566 |
| A | A61 | A61B2017/1107 |
| A | A61 | A61B2017/1121 |
| A | A61 | A61B2017/1125 |
| A | A61 | A61B2017/1132 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Surgical Intervention Technologies, specifically minimally invasive anastomosis techniques, biomedical device integration, and surgical procedure optimization involving medical instrumentation and data management systems
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or surgical technology specialist with advanced degrees, expertise in medical device design, familiarity with surgical intervention technologies, understanding of digital health integration, and knowledge of emerging medical technology trends
Obviousness Rationale
A PHOSITA would recognize that integrating digital technologies like AI, IoT, and blockchain with existing surgical techniques represents a predictable extension of known medical technology convergence trends. The fundamental anastomosis mechanism remains consistent with the source patent, while the added technological layers provide incremental improvements in monitoring, data management, and procedural optimization. The combination of known technologies to achieve enhanced surgical outcomes would be considered an obvious design progression within the field.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,193 |
|---|---|
| Title | Partial eversion anastomosis juncture formation and suturing |
| Assignee(s) | Gyrus ACMI, Inc. |